States are required to collect rebates on covered outpatient drugs administered by physicians in order to be eligible for Federal matching funds (SSA § 1927(a)). Previous OIG work identified significant concerns with States’ efforts in obtaining rebates for these physician-administered drugs.
White Collar, llc has extensive experience with audits and examining CMS’s policies and procedures to ensure States appropriately collect Medicaid rebates on physician-administered drugs.